It has been recently shown that VP-16-213, a semi-synthetic derivative of podophyllotoxin, inhibits the function of mammalian DNA topoisomerase II. In the present study, we examined the effects of VP-16-213 on the replication of herpes simplex virus type 2 (HSV-2). The compound did not inhibit the synthesis of early viral polypeptides at concentrations at which viral DNA synthesis was strongly suppressed, but induced double-strand breaks in newly synthesized HSV DNA. Electron microscopic examination of treated cells revealed the presence of a number of capsids with empty or partial cores. The level of topoisomerase II activity remained unaltered after infection, and all attempts to isolate VP-16-213-resistant mutants of HSV-2 have failed in spite of extensive efforts. It is suggested therefore that the mode of action of VP-16-213 may be inhibition of viral DNA synthesis by impairing the function of host cell topoisomerase II.
Effects of the Epipodophyllotoxin VP-16-213 on Herpes Simplex Virus
Type 2 It has been recently shown that VP-16-213, a semi-synthetic derivative of podophyllotoxin, inhibits the function of mammalian DNA topoisomerase II. In the present study, we examined the effects of VP-16-213 on the replication of herpes simplex virus type 2 (HSV-2). The compound did not inhibit the synthesis of early viral polypeptides at concentrations at which viral DNA synthesis was strongly suppressed, but induced double-strand breaks in newly synthesized HSV DNA. Electron microscopic examination of treated cells revealed the presence of a number of capsids with empty or partial cores. The level of topoisomerase II activity remained unaltered after infection, and all attempts to isolate VP-16-213-resistant mutants of HSV-2 have failed in spite of extensive efforts. It is suggested therefore that the mode of action of VP-16-213 may be inhibition of viral DNA synthesis by impairing the function of host cell topoisomerase II.
It is known that initiation of herpes simplex virus (HSV) DNA replication requires prior synthesis of immediate early (~) and early (fl) polypeptides. Some of the early peptides, such as viral DNA polymerase and the 130000 mol. wt. (130K) major DNA-binding protein, have been demonstrated to be involved in viral DNA replication by using temperature-sensitive and drugresistant mutants (Purifoy & Benyesh-Melnick, 1975 ; Hay & Subak-Sharpe, 1976; Conley et al., 1981 ; Littler et al., 1983; Leinbach et al., 1984) . The alkaline nuclease induced by HSV also may play a role in viral DNA replication (Francke & Garrett, 1982; Banks et al., 1983) . It seems reasonable to assume that more than three proteins, whether of viral or cellular origin, are involved in the replication of HSV DNA, since it is known that nearly ten proteins are required for replication of the Escherichia coli chromosome in vitro (Kaguni & Kornberg, 1984) . One approach to identifying such unknown proteins and to determining their functions is to use compounds that inhibit DNA synthesis. Recently, a semi-synthetic derivative of podophyllotoxin, VP-16-213, which can induce DNA breaks in cultured mammalian cells, has been shown to interfere with the function of mammalian DNA topoisomerase II (Wozniak & Ross, 1983; Chen et al., 1984; Long et al., 1984; Ross et al., 1984) . It has also been shown that VP-16-213 does not intercalate or bind to DNA (Ross et al., 1979) . It has therefore been suggested that DNA topoisomerase II is the target of VP-16-213 in vivo (Chen et al., 1984; Ross et al., 1984) . In this study, we examined the effects of VP-16-213 on the replication of HSV type 2 (HSV-2) in human embryonic fibroblasts.
Human embryonic fibroblasts (HEF) were prepared as described previously (Nishiyama et al., 1983) , grown in Eagle's MEM supplemented with 10~ foetal calf serum (FCS), 100 units/ml penicillin and 100 gg/ml streptomycin. HSV-2 strain 186 was obtained from Dr Fred Rapp, Pennsylvania State University College of Medicine, Hershey, Penn., U.S.A. The virus stock was prepared in HEF by infecting at low multiplicities (0.01 to 0.1 p.f.u./cell) as described 0000-7489© 1987 SGM previously (Nishiyama & Rapp, 1981 (Liu, 1983; Nelson et al., 1984; Nishiyama et al., 1984) .
To assess the antiviral effect of VP-16-213, both plaque reduction and yield reduction assays were performed in confluent cultures of HEF. Plaque formation with HSV-2 was inhibited by 50 ~ at 5 ~tg/ml of VP-16-213 and completely suppressed at 15 ~tg/ml (Fig. 1 a) . In yield reduction assays, cells were infected with HSV-2 at a multiplicity of approximately 10 p.f.u./cell and treated with the drug after 1 h adsorption. As shown in Fig. 1 (b inhibitor for confluent HEF was monitored for 48 h by microscopy. No significant morphological changes were observed in cultures treated with 20 gg/ml VP-16-213. However, treatment with 100 l.tg/ml resulted in cell rounding within 24 h.
Next, experiments were performed to determine the effect of VP-16-213 on HSV-2-induced protein synthesis. Cells infected with HSV-2 were treated with VP-16-213 for 2 h after 1 h adsorption and labelled with [ 35S]methionine between 3 and 4 h post-infection in the presence of the drug. As shown in Fig. 2 , addition of 20 gg/ml VP-16-213 had little effect on the synthesis of early viral polypeptides. In cultures treated with 100gg/ml VP-16-213, however, protein synthesis was inhibited by more than 95~o.
To examine the effect of VP-16-213 on viral and cellular DNA synthesis, CsC1 density gradient equilibrium centrifugation was performed as described previously (Nishiyama & Rapp, 1981) . Confluent monolayers of HEF were infected with HSV-2 at a multiplicity of approx. 20 p.f.u./cell, and labelled with [3H]thymidine (10 gCi/ml) between 2.5 and 3.5 h postinfection in the presence or absence of VP-16-213. When the inhibitor was added to cultures 30 rain before labelling at 20 gg/ml, the incorporation of [3H]thymidine into viral DNA was almost completely inhibited. Cellular DNA synthesis was also inhibited by the drug, but appeared less sensitive than viral DNA synthesis in this system. Therefore, the sensitivity of cellular DNA synthesis to VP-16-213 was measured independently in actively growing HEF, and compared with that of viral DNA synthesis. As shown in Fig. 3 , the inhibition curve of cellular DNA synthesis was quite similar to that of viral DNA synthesis, indicating that viral and cellular DNA syntheses are equally sensitive to this drug.
It has been shown that VP-16-213 can induce single-strand and double-strand DNA breakages in vivo (Long et al., 1984) . In simian virus 40 (SV40)-infected cells, treatment with epipodophyllotoxins results in conversion of supercoiled SV40 DNA into linear and nicked forms (Chen et al., 1984) . In order to test whether VP-16-213 induced double-strand DNA breaks in HSV DNA, the sedimentation behaviour of newly synthesized viral DNA was examined in neutral sucrose gradients. Infected cells were pulse-labelled with [3H]thymidine for 30 min between 3 and 3.5 h post-infection since more than 85 ~ of the DNA synthesis during this period was viral (data not shown). The cells were then chased for 1 h in the presence of 20 txg/ml VP-16-213 or 10 mM-hydroxyurea, or in the absence of these drugs. To avoid DNA breakage, the cells were carefully treated with SDS, digested with proteinase K, and a sample was layered directly onto neutral sucrose gradients. The size distribution profiles are illustrated in Fig. 4 . In the gradient of DNA from control cultures, a single peak of radioactivity was observed in the position that corresponded to that of mature viral DNA (55S) in a parallel gradient. The distribution profile was not affected by inhibition of DNA synthesis with hydroxyurea. In contrast, the labelled DNA from VP-16-213-treated cells sedimented in the gradient as a broad peak with a shoulder in the lower molecular weight region.
We also measured the level of DNA topoisomerases I and II, and viral DNA polymerase activities at various times after infection. The activity of viral DNA polymerase became detectable by 2 h post-infection and increased until 8 h. However, the level of DNA-relaxing activity of both topoisomerases I and II remained constant for at least 10 h after infection (data not shown). Although we examined the level of topoisomerase II under several assay conditions, no detectable change was observed.
The data described above indicated that VP-16-213 inhibited the replication of HSV-2 at the stage of viral DNA synthesis, and it was inferred that the inhibition may be due to interference in a function of DNA topoisomerase II. If the target of VP-16-213 is encoded by the viral genome, it should be possible to isolate drug-resistant mutants. To test this possibility, we tried to isolate such mutants but in spite of extensive efforts all attempts have failed.
To determine whether VP-16-213 has any inhibitory effect on HSV-2 morphogenesis, electron microscopical studies were also performed. Cultures were treated with 20 gg/ml VP-16-213 from 1 h post-infection and fixed with glutaraldehyde 9 h post-infection. A number of viral capsids were observed even in the nuclei of infected cells treated with VP-16-2 l 3, but most were incomplete with empty or partial cores (data not shown).
Many investigators have studied the effects of podophyllotoxin and its derivatives on the growth of mammalian cells (Keller-Juslen et al., 1971 ; Grieder et al., 1974) . Earlier studies have shown that two derivatives, VP-16-213 and VM-23, have a different mechanism of action from that of the parent compounds. Neither derivative, unlike podophyllotoxin, affects microtubule assembly but both induce DNA strand breakage (Loike & Horwitz, 1976a, b) . Recently, Chen et al. (t984) have reported that VP-16-213 and VM-23, neither of which intercalate or bind to DNA, interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II by stabilizing a cleavable complex, and suggested that the DNA breakage activity in vivo of these epipodophyllotoxins is mediated by topoisomerase II. Using SV40-infected cells they have also shown that the epipodophyltotoxins induce both single-strand and double-strand breaks in viral DNA. HSV DNA is known to have single-strand nicks and gaps naturally (Wilkie, 1973) , but neutral sucrose gradient sedimentation analysis showed that VP-16-213 induced double-strand DNA breaks only in newly synthesized HSV DNA in vivo. Our results and previous observations taken together suggest that DNA topoisomerase II is involved in the replication of HSV DNA and that VP-16-213 inhibits viral DNA synthesis by interfering with the function of topoisomerase II.
To our knowledge there are three reports on HSV-related topoisomerases. Biswal et al. (1983) have reported that a DNA-relaxing enzyme which has a strict requirement for Mg 2÷ and ATP co-purified with HSV-l-induced DNA polymerase. Leary & Francke (1984) have described an enzyme activity induced in HSV-l-infected cells which is capable of catenating closed circular DNA in the presence of Mg 2+, but this enzyme did not require ATP. Muller et al. 0985) have recently shown that a type I topoisomerase which did not require ATP or Mg 2+ for activity was associated with purified virions of HSV-1. At present, however, there is no clear evidence that these DNA topoisomerases are virus-coded. Although we cannot present direct evidence, our observations suggest that the topoisomerase II involved in the replication of HSV DNA may be of host cell origin. The reasons are as follows: (i) the sensitivity of viral DNA synthesis to VP-16-213 was very similar to that of cellular DNA synthesis, (ii) there was no change in the level of topoisomerase II activity following infection with HSV and (iii) extensive efforts to isolate HSV mutants resistant to VP-16-213 failed, whereas a number of viral DNA polymerase mutants resistant to inhibitors were isolated in parallel experiments. In order to resolve this issue directly, it will be necessary to examine the antiviral effect of VP-16-213 in VP-16-213-resistant cells that have an altered cellular topoisomerase II.
